International Patient Summary Implementation Guide
2.0.0 -

International Patient Summary Implementation Guide, published by HL7 International / Patient Care. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ips/ and changes regularly. See the Directory of published versions

## Example Observation: Observation: imaging CT Abdomen W contrast IV, sub-observations

Page standards status: Informative

Language: en

Profile: Observation Results - Radiology (IPS)

partOf: ImagingStudy: identifier = urn:dicom:uid#DICOM Unique Id#urn:oid:2.16.840.1.113883.2.9.999.1.12345; status = available; procedureCode = SPECT Heart perfusion and wall motion at rest and W stress and W Tl-201 IV and W Tc-99m Sestamibi IV; reasonCode =

status: Final

category: Imaging

code: Upper abdomen with the administration of oral and intravenous contrast (example-4)

subject: Alexander Heig Male, DoB: 1957 ( http://trilliumbridge.eu/fhir/demos/eumfh/inject#39-07)

effective: 1995-06-08

performer:

- Practitioner Mark Antonio
- Organization Someplace General Hospital

value: 3 cm nodule present in the inferior medial aspect of right liver lobe. Contrast enhancement pattern consistent with the diagnosis of hemangioma.

> component

> code: Procedure Description

> value: Serial imaging was obtained in the upper abdomen with the administration of oral and intravenous contrast.

> component

> code: Finding

> value: The examination demonstrates a well circumscribed 3 cm lesion present within the medial aspect of the inferior right liver lobe. Initial evaluation demonstrates lack of contrast enhancement. Subsequent imaging (not shown) demonstrated typical contrast enhancement pattern of a benign hemangioma of the liver. The remaining contrast enhancement pattern in the liver is normal. There is normal appearance of the adrenal glands, spleen, kidneys, and pancreas. There is no evidence of liver metastasis.